India, Mar 27, 2014
(BUSINESS WIRE) -- Dr. Reddy’s Laboratories announced today that it has
launched Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10mg,
2.5/20mg, 2.5/40mg, 5/10mg, 5/20mg, 5/40mg, 5/80mg, 10/10mg, 10/20mg, 10/40mg
and 10/80 mg a therapeutic equivalent generic version of CADUET® (amlodipine
Besylate and atorvastatin calcium) tablets, in the US market on March 26, 2014,
following the approval by the United States Food & Drug Administration
(USFDA).
The CADUET tablets brand
and generic had U.S. sales of approximately $163 Million MAT for the most
recent twelve months ending in January 2014 according to IMS Health*.
Dr. Reddy’s Amlodipine
Besylate and Atorvastatin Calcium Tablets are available in bottle counts of 30
and 90**.
Disclaimer
This press release
includes forward-looking statements, as defined in the U.S. Private Securities
Litigation Reform Act of 1995. We have based these forward-looking statements
on our current expectations and projections about future events. Such
statements involve known and unknown risks, uncertainties and other factors
that may cause actual results to differ materially. Such factors include, but
are not limited to, changes in local and global economic conditions, our
ability to successfully implement our strategy, the market acceptance of and
demand for our products, our growth and expansion, technological change and our
exposure to market risks. By their nature, these expectations and projections
are only estimates and could be materially different from actual results in the
future.
No comments:
Post a Comment